TempTraq

Name

TempTraq

Legal name

Blue Spark Technologies, Inc.

Website

https://temptraq.healthcare

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Continuous Patient Temperature Monitoring Medical Devices

NAICS

Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Continuous Temperature & Fever Monitoring (Wearable Thermometry) (HLAHACAK)

akta.pro secondary industry

Clinical Trial Management Systems (CTMS) (HLACAOAD)

Keywords

• Continuous temperature monitoring
• Remote patient monitoring
• Wireless medical devices
• Clinical temperature sensors
• Healthcare monitoring patches

Headquarters

HQ city

Westlake

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. Disposable Temperature Monitoring Patches: Single-use disposable patches sold to healthcare facilities. Each patch operates for 72 hours before disposal. Revenue generated through direct hospital procurement and supply chain relationships with healthcare systems.
2. TempTraq Connect Cloud Platform: HIPAA-compliant cloud service for data transmission and monitoring. Likely subscription-based service for healthcare systems requiring continuous monitoring infrastructure.
3. Clinical Trial Technology Services: Partnership arrangements with pharmaceutical companies for clinical trial monitoring services using TempTraq technology, including studies with Bristol Myers Squibb, Duke Medical Center, and MD Anderson.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

TempTraq is an FDA Cleared Class II medical device consisting of a soft, disposable adhesive patch that continuously monitors body temperature in real-time for up to 72 hours, transmitting data via Bluetooth Low Energy to mobile devices or hospital systems. The product is complemented by TempTraq Connect, a HIPAA-compliant cloud platform integrated with EHR and central monitoring systems, and VitalTraq, a multi-sensor remote patient monitoring platform with AI-powered contactless technologies launched in January 2024.

Product overview

TempTraq is a single-product medical device company (Blue Spark Technologies) offering the FDA Cleared TempTraq wireless continuous temperature monitoring patch as its core product. The product ecosystem includes TempTraq Connect, a HIPAA-compliant cloud service for data management and EHR integration. In January 2024, the company expanded its portfolio with VitalTraq, a new multi-sensor remote patient monitoring platform featuring AI contactless technologies. The original TempTraq patch remains the flagship offering—a disposable 72-hour temperature monitor using Bluetooth connectivity, while VitalTraq represents a significant platform expansion into broader vital sign monitoring.

Differentiator

Problem solved

Functional benefit

Brands

• TempTraq Connect: HIPAA-compliant cloud service platform that integrates with hospital central monitoring stations and electronic health records
• VitalTraq

Products and services

• TempTraq An FDA Cleared Class II medical device consisting of a soft, disposable adhesive patch that continuously monitors body temperature for up to 72 hours, transmitting real-time data via Bluetooth Low Energy to compatible mobile devices or hospital systems for use by clinicians, hospitals, and home caregivers.
• TempTraq Connect HIPAA-compliant cloud service that receives and processes temperature data from TempTraq patches, supports HL7-based integration with hospital central monitoring stations and EHRs, and enables remote monitoring via Apple iOS or Android mobile devices for healthcare providers and caregivers.
• VitalTraq Multi-sensor remote patient monitoring platform with AI-powered contactless technologies launched in January 2024, expanding beyond single-parameter temperature monitoring into comprehensive vital sign digital measurements for healthcare providers.

Quantifiable outcome

• Fever detection 140.1 minutes earlier (median, range 30-180 minutes) than standard of care in stem cell transplant patients
• +6 more outcomes

Named customers8 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration7 records

AI capability3 records

Feature6 records

Partnerships

Five partnerships are on record, tiered core.

• Duke Medical CentercoreStrategic or Co-development Partner · 4 November 2025Prospective trial at Duke evaluating remote patient monitoring platform for earlier detection of cytokine release syndrome after bispecific T cell engager and CAR-T therapies. Study showed 93.1% compliance for TempTraq and 28.2 hours faster CRS detection.
• MD Anderson Cancer CentercoreStrategic or Co-development Partner · 4 November 2025Longitudinal observational matched cohort study assessing outpatient cilta-cel administration using TempTraq for high-frequency temperature monitoring. Reduced median inpatient stay by 5 days and costs by $19,180 per patient.
• Medidata (Dassault Systèmes)coreTechnology or Integration · 29 June 2022Blue Spark Technologies joined Medidata's Sensor Cloud Network, one of nine organizations in this expanded network. The collaboration aims to overcome barriers limiting full adoption of medical sensors including data integration and standardization, and fuel development of new digital health technologies.
• Carevive SystemscoreStrategic or Co-development Partner · 7 April 2022Partnership with Carevive Systems, the leading oncology-focused health technology company, to conduct a real-time remote patient monitoring pilot. The collaboration aims to prevent symptoms in advance with contextualized data for cancer patient care.
• Bristol Myers SquibbcoreStrategic or Co-development Partner · 18 May 2021Observational trial using TempTraq wearable Bluetooth continuous body temperature monitoring platform with CAR T therapies developed by Bristol Myers Squibb for patient monitoring during treatment.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Masimo: Masimo is a leading patient monitoring incumbent with a broad portfolio of continuous vital sign monitoring technologies deployed in hospitals; its wearable and SET pulse oximetry products compete with TempTraq in hospital continuous monitoring and could expand into temperature.
• GE HealthCare (Patient Monitoring): GE HealthCare provides continuous patient monitoring solutions including bedside monitors and central stations deployed across hospital systems globally; its installed base and clinical workflow integration represent both a competitive threat and a potential integration channel for TempTraq.
• Philips (Patient Monitoring): Philips offers the IntelliVue and similar continuous patient monitoring platforms used in hospitals worldwide, representing a broad incumbent competitor with overlapping continuous vital sign monitoring capabilities that TempTraq must displace or integrate with.
• Medtronic (Patient Monitoring): Medtronic's patient monitoring business offers continuous vital sign monitoring solutions across hospital and remote care settings, including capnography and brain monitoring; it competes with TempTraq in the broader continuous monitoring category and could expand into wearable temperature.

Direct peers

• Raiing Medical (iThermonitor): Raiing's iThermonitor is a wireless continuous temperature monitoring wearable patch designed for fertility tracking and clinical use, competing directly with TempTraq in the wearable continuous temperature monitoring category.
• VivaLnk (FeverScout): VivaLnk's FeverScout is a disposable wearable continuous temperature monitoring patch with similar Bluetooth connectivity and 72-hour wear cycle, making it the closest direct competitor to TempTraq in the wearable thermometry category for clinical and consumer use cases.

Emerging players

• Sibel Health: Sibel Health develops flexible, wireless wearable sensors for continuous vital sign monitoring in clinical and decentralized trial settings, with overlapping patient monitoring and clinical trial use cases that directly intersect with TempTraq's patch and platform approach.
• Empatica: Empatica produces FDA-cleared wearable sensors for continuous health monitoring including temperature, used in clinical trials and neurology; it is comparable to TempTraq as a small wearable sensor company with FDA clearance and clinical trial distribution channels.
• BioIntelliSense: BioIntelliSense offers the BioSticker and BioButton continuous multi-parameter remote patient monitoring wearables, competing in the same clinical RPM category as TempTraq's expanded VitalTraq platform with a focus on hospital-to-home transitions.

Others

• Carevive Systems: Carevive Systems is an oncology-focused digital health company that partnered with TempTraq to run a remote patient monitoring pilot for cancer patients; it is an ecosystem partner rather than a competitor, operating in the adjacent oncology digital therapeutics and PRO space.

Market position

Strengths5 records

Weaknesses3 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TempTraq